| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Artemether | Artemether EP Impurity A | VL4140001 | View CAS 1093625-96-7 |
| Artemether | Artemether EP Impurity C | VL4140003 | View CAS 181528-64-3 |
| Artemether | Artemether Impurity 1 | VL4140002 | View |
| Artemether | Artemether Related Compound A | VL4750001 | View CAS 71939-50-9 |
| Artemether | Artemether Related Compound B | VL3850079 | View CAS 71939-51-0 |
| Artemether | Artemether-D3 | DVE0052 | View |
| Artemether | 2-(4-Methyl-2-oxo-3-(3-oxobutyl)cyclohexyl)propanal | VE009245 | View |
| Catalogue No. | VL4140001 |
| CAS No. | 1093625-96-7 |
| Molecular Formula | C₁₄H₂₂O₃ |
| Molecular Weight | 238.32 |
| Parent drug | Artemether |
| IUPAC Name | (2S, 3R, 6RS)-2-(3-Oxobutyl)-3-methyl-6-[(R)-2-propanal]cyclohexanone |
| Synonyms | N/A |
| References | “Artemether – an Overview, ScienceDirect Topics.” http://Www.sciencedirect.com, http://www.sciencedirect.com/topics/neuroscience/artemether. Accessed 21 Jan. 2022. |
| Status | In-stock |
| ListName | Artemether EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
